NCT06326112View on ClinicalTrials.gov

Role of Active Deresuscitation After Resuscitation:

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

June 30, 2025

Conditions
Fluid OverloadCritical IllnessSepsisARDSTrauma
Interventions
DRUG

Furosemide Injection

o.5 mg/kg bid or tid IV

DRUG

Metolazone Tablets

Diuretic as needed

Trial Locations (1)

M5B 1W8

Unity Health Toronto, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Unity Health Toronto

OTHER